top of page
Starting August 1, 2024, Quickarrays Inc. will be taking over Pantomics Inc. to
provide all products and services. Please visit Quickarrays Inc. for more information.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
Hermatopathology
OVC481
Ovary cancer tissue array, 16 cases, 48 cores, non-over lapping with OVC241, one normal ovary tissue core paired with two tumor tissue cores from each patient, with grading and TNM staging data.
Price per slide:
$246
Species:
Human
Cases:
16
Cores:
48
Core Size:
2.0mm
Core Thickness:
4um
Rows:
6
Columns:
8
Format:
Intended Usage:
For research use only. Designed for normal vs cancer IHC or ISH based protein or RNA tissue profiling in ovary cancers.
6
X
8
For illustration purpose only. Actual product may vary.
Notes:
All the tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They can be stored for use at 4C for up to six months from the date of shipment. There may be 5 to 10% of tissue core loss.
Bake at 60C for ~60 minutes before use. If antigen retrieving is needed, it is important to avoid direct-boiling and high pH or high strength antigen retrieving buffer. For availability of complimentary IHC data, please contact us at info@pantomics.com.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | NATURE | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|---|
A01 |  | F | 36 | Ovary | Serous cystadenocarcinoma | Malignant | I | T1N0M0 |
A02 |  | F | 61 | Ovary | Serous cystadenocarcinoma | Malignant | II | T1N1M0 |
A03 |  | F | 38 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N0M1 |
A04 |  | F | 49 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T1N0M0 |
A05 |  | F | 75 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N0M0 |
A06 |  | F | 56 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
A07 |  | F | 72 | Ovary | Serous cystadenocarcinoma | Malignant | I | T2N0M0 |
A08 |  | F | 69 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
B01 |  | F | 36 | Ovary | Serous cystadenocarcinoma | Malignant | I | T1N0M0 |
B02 |  | F | 61 | Ovary | Serous cystadenocarcinoma | Malignant | II | T1N1M0 |
B03 |  | F | 38 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N0M1 |
B04 |  | F | 49 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T1N0M0 |
B05 |  | F | 75 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N0M0 |
B06 |  | F | 56 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
B07 |  | F | 72 | Ovary | Serous cystadenocarcinoma | Malignant | I | T2N0M0 |
B08 |  | F | 69 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
C01 |  | F | 36 | Ovary | Uninvolved ovary tissue of A1,B1 | Normal | ||
C02 |  | F | 61 | Ovary | Uninvolved oavry tissue of A2,B2 | Normal | ||
C03 |  | F | 38 | Ovary | Uninvolved ovary tissue of A3,B3 | Normal | ||
C04 |  | F | 49 | Ovary | Uninvolved ovary tissue of A4,B4 | Normal | ||
C05 |  | F | 75 | Ovary | Uninvolved ovary tissue of A5,B5 | Normal | ||
C06 |  | F | 56 | Ovary | Uninvolved ovary tissue of A6,B6 | Normal | ||
C07 |  | F | 72 | Ovary | Uninvolved ovary tissue of A7,B7 | Normal | ||
C08 |  | F | 69 | Ovary | Uninvolved ovary tissue of A8,B8 | Normal | ||
D01 |  | F | 41 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N0M1 |
D02 |  | F | 52 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N0M0 |
D03 |  | F | 55 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N0M0 |
D04 |  | F | 46 | Ovary | Serous cystadenocarcinoma | Malignant | III | T2N0M0 |
D05 |  | F | 45 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T2N0M0 |
D06 |  | F | 48 | Ovary | Undifferentiated carcinoma | Malignant | T1N0M0 | |
D07 |  | F | 53 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T3N0M0 |
D08 |  | F | 65 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
E01 |  | F | 41 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N0M1 |
E02 |  | F | 52 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N0M0 |
E03 |  | F | 55 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N0M0 |
E04 |  | F | 46 | Ovary | Serous cystadenocarcinoma | Malignant | III | T2N0M0 |
E05 |  | F | 45 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T2N0M0 |
E06 |  | F | 48 | Ovary | Undifferentiated carcinoma | Malignant | T1N0M0 | |
E07 |  | F | 53 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T3N0M0 |
E08 |  | F | 65 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
F01 |  | F | 41 | Ovary | Uninvolved ovary tissue of D1,E1 | Normal | ||
F02 |  | F | 52 | Ovary | Uninvolved ovary tissue of D2,E2 | Normal | ||
F03 |  | F | 55 | Ovary | Uninvolved ovary tissue of D3,E3 | Normal | ||
F04 |  | F | 46 | Ovary | Uninvolved ovary tissue of D4,E4 | Normal | ||
F05 |  | F | 45 | Ovary | Uninvolved ovary tissue of D5,E5 | Normal | ||
F06 |  | F | 48 | Ovary | Uninvolved ovary tissue of D6,E6 | Normal | ||
F07 |  | F | 53 | Ovary | Uninvolved ovary tissue of D7,E7 | Normal | ||
F08 |  | F | 65 | Ovary | Uninvolved ovary tissue of D8,E8 | Normal |
bottom of page